Nina Cosdon

Six confirmed cases of malaria in Florida and 1 in Texas have not been linked to international travel.

The FDA committee, known as VRBPAC, in charge of evaluating vaccines and related biological products recently voted unanimously that the upcoming 2023-2024 COVID-19 vaccines should be updated with a monovalent XBB strain.

Although older adults have 2 vaccines, this would be the first vaccine or antiviral option for infants.

The FDA's decision to approve Abrysvo was based on data from a Phase 3 clinical trial, RENOIR, demonstrating the RSV vaccine's efficacy, immunogenicity, and safety in adults 60 and older.

The CDC updated and simplified its vaccine recommendations on April 19, 2023, and the Moderna and Pfizer-BioNTech mRNA bivalent COVID-19 vaccines should be used for all vaccinations in the US.

Hepatitis B prevention needs more real-world studies, according to an expert who gave a presentation at CROI.

COVID-19 reinfection chances vary to variant and time since the previous infection, according to a new study.

The CDC genomic surveillance found that the XBB.1.5 variant has increased from causing 1% to over 40% in only a month.

The respiratory syncytial virus demonstrates effectiveness analyzing severity, age group, and comorbidity in the phase 3 vaccine trial.

Identified in at least 35 people in eastern China, a new type of henipavirus, Langya virus, is suspected to have infected shrews before jumping to humans.

Children 5 to 11 years old now can receive a booster shot of the Pfizer-BioNTech vaccine.

The postponement will allow for additional time to review new data regarding the emergency use authorization request.

Investigators found that 32% of older adults diagnosed with COVID-19 sought medical attention in the post-acute period.

In making the ruling, the FDA stated that it wants to spare patients the risk of side effects such as injection site soreness or allergic reactions for treatments unlikely to work.

This frequency of symptoms 1 year after recovering from severe COVID-19 disease is concerning, as much is still unknown about “long COVID.”

Despite the preliminary evidence that a fourth dose will not offer sufficient protection against Omicron, Israel will continue to offer it to vulnerable populations, predicting that the variant’s contagions will wane.

Data collected from over 46,000 pregnant women show that COVID-19 vaccination does not cause an increased risk of preterm birth or small-for-gestational-age at birth.

If CDC Director Rochelle Walensky, MD, endorses the FDA’s decision, the recommendation can go into effect this week.

Any COVID-19 vaccine is better than none. But the CDC recommends that people get the Janssen vaccine only if they can’t get the Pfizer/BioNTech or Moderna vaccines.

Perhaps another reason why pregnant women should get the COVID-19 vaccine? Investigators found COVID-19 infection altered the mothers’ immunity at delivery, and gestational COVID-19 exposure alters the immunity of the newborns.

Results unveiled at IDWeek 2021 disprove any misconceptions about pediatric COVID-19 cases lacking severity.